Interestingly, Debio-0719, an inhibitor of lysophosphatidic acid receptor 1 (LPA1), was shown to induce tumor dormancy of triple-negative breast cancer (TNBC) cells at distant organs by inducing the p38high–ERKlow signaling axis (67). The gene discussed is LPAR1; the disease is triple-negative breast carcinoma.